Professional Documents
Culture Documents
Objective: This report describes 1-, 2-, and 3-year outcomes of a combined psychosocial
skills training and preventive healthcare intervention (Helping Older People Experience
Success [HOPES]) for older persons with serious mental illness. Methods: A randomized
controlled trial compared HOPES with treatment as usual (TAU) for 183 older adults
(age ! 50 years [mean age: 60.2]) with serious mental illness (28% schizophrenia, 28%
schizoaffective disorder, 20% bipolar disorder, 24% major depression) from two
community mental health centers in Boston, Massachusetts, and one in Nashua, New
Hampshire. HOPES comprised 12 months of weekly skills training classes, twice-
monthly community practice trips, and monthly nurse preventive healthcare visits,
followed by a 1-year maintenance phase of monthly sessions. Blinded evaluations of
functioning, symptoms, and service use were conducted at baseline and at a 1-year (end
of the intensive phase), 2-year (end of the maintenance phase), and 3-year (12 months
after the intervention) follow-up. Results: HOPES compared with TAU was associated
with improved community living skills and functioning, greater self-efficacy, lower
overall psychiatric and negative symptoms, greater acquisition of preventive healthcare
(more frequent eye exams, visual acuity, hearing tests, mammograms, and Pap smears),
and nearly twice the rate of completed advance directives. No differences were found for
medical severity, number of medical conditions, subjective health status, or acute service
use at the 3-year follow-up. Conclusion: Skills training and nurse facilitated preventive
healthcare for older adults with serious mental illness was associated with sustained
long-term improvement in functioning, symptoms, self-efficacy, preventive healthcare
screening, and advance care planning. (Am J Geriatr Psychiatry 2014; 22:1251e1261)
Received September 25, 2012; revised March 28, 2013; accepted April 24, 2013. From the Department of Psychiatry (SJB, SIP, KTM, KAA) and
Department of Community and Family Medicine (SJB), Geisel School of Medicine at Dartmouth, Hanover, NH; The Dartmouth Institute for
Health Policy and Clinical Practice (SJB, SIP, JAN), Dartmouth College, Hanover, NH; Dartmouth Psychiatric Research Center (KTM, RW,
HX, GJM), Lebanon, NH; Center for Psychiatric Rehabilitation (KTM), Boston University, Boston, MA; Department of Psychiatry (BPF),
Harvard University, Cambridge, MA; Geriatric Psychiatry Research Program (BPF), McLean Hospital, Belmont, MA; Schizophrenia Program
(CC), Massachusetts General Hospital, Boston, MA; Vinfen (BB), Cambridge, MA; and Massachusetts Mental Health Center (JF), Boston, MA.
Send correspondence and reprint requests to Stephen J. Bartels, M.D., M.S., Centers for Health and Aging, 46 Centerra Parkway, Ste. 200,
Lebanon, NH 03766. e-mail: sbartels@dartmouth.edu
! 2014 American Association for Geriatric Psychiatry
http://dx.doi.org/10.1016/j.jagp.2013.04.013
Key Words: Older adults, serious mental illness, psychosocial skills training, healthcare
management, preventive healthcare, integrated care
mental health agencies in Boston, Massachusetts, and conjunction with documented persistent impairment
one in Nashua, New Hampshire, and were random- in multiple areas of functioning. Exclusion criteria
ized to HOPES (N ¼ 90) or TAU (N ¼ 93). Eligibility were residence in a nursing home or other institu-
criteria included ability and willingness to provide tional setting, primary diagnosis of dementia or
informed consent and an Axis I disorder diagnosis of significant cognitive impairment as indicated by
schizophrenia, schizoaffective disorder, bipolar a Mini Mental Status Exam score less than 20,21
disorder, or major depression based on the Struc- physical illness expected to cause death within
tured Clinical Interview for Diagnostic and Statistical 1 year, or current substance dependence. Figure 1
Manual of Mental Disorders, Fourth Edition20 in summarizes the flow of participants in the study.
interviewer. Randomization was conducted at the and the correlation between baseline and 3-year
individual level and stratified by diagnosis (schizo- outcomes. The following thresholds, defined by
phrenia spectrum or mood disorder) and gender. A Cohen,37 were used to determine whether an effect
block randomization approach was used to ensure size was small (0.20), moderate (0.50) or large (0.80).
that no more than four participants could be Positive effect sizes denote increases in HOPES rela-
randomized to the same treatment group in a row. tive to TAU, and negative effect sizes denote
Participants were paid for completing assessments decreases in HOPES relative to TAU.38
but not for participating in HOPES. Chi-square analyses and number needed to treat
(NNT)39 were used to evaluate the categorical
outcomes of receipt of preventive healthcare. As
Statistical Analyses
determined in a prior study,40 NNT for one person to
Sample size was determined by computing statis- obtain preventive health screening, cancer screening,
tical power to detect effect sizes based on our pilot or completion of advance directives was calculated as
study of the HOPES program.16 Two tailed t tests and the inverse of the absolute risk reduction for not
c2 analyses were used to compare HOPES and TAU receiving either of these types of preventive healthcare.
on demographic characteristics, psychiatric history,
and outcome measures at baseline. Treatment effects
were evaluated by conducting intent-to-treat anal-
yses on the full sample of randomized study partic- RESULTS
ipants, regardless of their exposure to treatment.
HOPES Versus TAU at Baseline and 3-Year
A mixed-effects linear model was used for analysis,
Follow-Up
which does not drop subjects with missing data
because the statistical inference model assumes data Participants assigned to HOPES did not differ
missing at random. A doubly multivariate repeated significantly from those assigned to TAU on any
measures analysis of variance, simultaneously demographic, diagnostic, or baseline measures, with
analyzing all three dependent measures of commu- the exception of a greater rate of asthma in HOPES
nity functioning, guarded against potential inflation compared with TAU group (N ¼ 18 versus N ¼ 7;
of alpha with multiple dependent variables. There- p ¼ 0.017) (Table 1). We compared baseline demo-
after, an analysis of covariance approach controlling graphics, functioning, and symptoms of participants
for gender and diagnosis was used to test for treat- who completed the 3-year assessment (N ¼ 129) with
ment effects on each of the dependent variables those lost at the 3-year follow-up (N ¼ 54). Partici-
separately. Because there were no significant differ- pants lost to follow-up were slightly older (mean age:
ences between HOPES and TAU at baseline, rather 62.7 $ 9.3 versus 59.1 $ 7.1; t test ¼ 2.58; df ¼ 181;
than fitting parametric curves with random effects, p ¼ 0.01) and had greater self-efficacy (mean Revised
we included the baseline as a covariate and fit base- Self Efficacy Scale score: 72.5 $ 17.9 versus 65.6 $
line adjusted mean response profile models,34 also 19.0; t test ¼ %2.36; df ¼ 181; p ¼ 0.02).
referred to as covariance pattern models,35 selecting Fewer than 2% of observations were missing at
appropriate covariance structures as well as missing baseline for the Center for Epidemiologic Studies
data with maximum likelihood estimation.36 Depression Scale, Charlson Comorbidity Index, and
Site was included in initial analyses but was Brief Psychiatric Rating Scale. At the 3-year follow-
dropped from the final models because it did not up, an average of 34% of observations were missing
alter the main effects. Because the baseline was (range: 31%e39%), except for the Multnomah Scale,
statistically adjusted, treatment effects were evalu- which had 50% missing observations. This rate of
ated with group main effects (i.e., differences in missing observations was expected because 30%
group mean response profiles). Two-tailed statistical (N ¼ 54) of participants were lost at the 3-year
tests were conducted, and differences were consid- follow-up and the Multnomah Scale requires
ered statistically significant based on p #0.05. Effect locating and interviewing clinical providers who
sizes were computed using Cohen’s d and an anal- have detailed knowledge of participants’ functioning
ysis of covariance approach to adjust for covariates in the community.
0.033
0.024
0.014
0.190
0.010
p
and no significant relationship emerged.
Group Main Effect
1, 161
1, 150
1, 163
1, 162
1, 156
df
5.23
6.13
1.73
6.85
F
0.26
0.27
%0.08
0.33
had at least one psychiatric hospitalization, medical
ES
15.15
19.48
10.06
10.39
15.89
21.08
SD
0.68
0.62
3.83
3.72
77.77
70.30
48.56
50.29
72.20
69.45
14.35
21.06
8.41
9.58
16.37
18.49
SD
0.68
0.65
3.78
3.61
77.32
69.44
46.74
49.14
71.46
71.33
17.70
0.11
0.45
0.50
13.47
19.88
8.54
9.23
17.74
0.68
71.35
0.66
3.76
3.58
76.04
68.97
49.30
50.75
68.76
19.16
0.11
0.51
0.51
15.93
19.04
8.94
7.97
18.61
0.66
66.24
0.65
3.66
3.69
72.85
68.54
51.42
51.17
68.99
HOPES
HOPES
HOPES
HOPES
HOPES
TAU
TAU
TAU
TAU
TAU
DISCUSSION
Case manager/clinician
Participant interview/
Participant interview
Participant interview
Performance-based
observation
Data Source
of advanced directives.
These results contribute to a limited empirical
Measures
0.936
HOPES 46.90 11.56 45.54 11.97 47.94 12.22 46.09 13.25 0.07 0.12 1, 159 0.732
0.048
0.053
0.073
HOPES 3.03 2.49 2.77 2.48 2.72 2.52 2.73 2.43 %0.22 0.26 1, 156 0.614
HOPES 5.48 3.99 8.55 5.44 8.78 4.68 10.43 8.42 %0.14 0.10 1, 94 0.749
P
include an integrated component of preventive
Group Main Effect
0.65
14.27
14.88
41.99
19.52
50.53
49.92
2.21
2.50
19.43
41.99
13.27
0.55
0.65
13.18
SD
40.65
12.38
50.43
51.09
2.26
2.52
19.59
42.93
11.42
13.11
SD
TABLE 3. Psychiatric Symptoms and Health Status Outcomes at 3-Year Follow-Up in HOPES Compared with TAU
1 Year
41.77
20.01
52.82
54.34
2.29
2.51
20.63
41.27
12.82
13.81
SD
Baseline
38.99
23.85
55.54
54.23
2.42
2.50
20.83
41.25
HOPES
TAU
TAU
TAU
TAU
TAU
Participant interview/observation
Participant interview
Participant interview
Medical records
TABLE 4. Preventive Healthcare, Screening, and Advance Directives at 3-Year Follow-Up in HOPES Compared with TAUa
HOPES TAU
(N [ 90) (N [ 93)
Preventive Healthcare and Advance Directives N % N % NNT Effect Size c2 Testb p
Routine preventive care
Blood pressure 87 100 89 99 90.9 0.00 1.00 0.508
Eye exam 84 97 79 88 11.2 0.36 4.96 0.048
Visual acuity test 74 85 65 72 7.8 0.32 4.39 0.045
Hearing test 52 60 40 44 6.5 0.32 4.18 0.051
Cholesterol 84 97 84 93 30.3 0.13 0.97 0.497
Flu shot 75 86 68 76 9.4 0.26 3.28 0.087
Cancer screening
Colon cancer screen 71 82 76 84 %35.7c %0.07 0.25 0.690
Mammogram (women) 45 85 34 67 5.5 0.43 4.81 0.039
Pap smear (women) 41 77 25 49 3.5 0.59 9.16 0.004
Care planning
Advance directives 51 61 28 33 3.6 0.59 13.20 <0.001
a
Percent receiving preventive healthcare screening at least once over the 3-year study period and presence of documented advance
directives.
b
Fisher’s two-sided Exact Test.
c
Because a slightly greater proportion of TAU participants received colon cancer screening compared with HOPES participants, the NNT is
a negative value, more appropriately interpreted as number needed to harm.
after this trial, is now available. Second, because standards on clinical significance have not been
HOPES consists of both skills training and preventive established. However, the UCSD Performance-based
healthcare, we are unable to attribute the study Skills Assessment has an established cutoff for clini-
outcomes to either component. Third, the nurse cally significant improvement in functioning: a score
component emphasized preventive healthcare and of at least 75 is predictive of residential indepen-
healthcare coordination. We found improved quality dence.42 At the 3-year follow-up, two-thirds of
of preventive healthcare (a proximal outcome) but did HOPES participants achieved at least 75 on the UCSD
not demonstrate significant improvement in health Performance-based Skills Assessment (67%; N ¼ 37)
status (a distal outcome) as measured by the SF-36. compared with slightly more than half of those
More targeted disease management (as opposed to receiving TAU (54%; N ¼ 30) (NNT ¼ 7.3).
general care coordination) and a longer follow-up These findings advance the evidence base on
period may be needed to demonstrate improved effective interventions for older adults with SMI in
health outcomes. several ways. Our study demonstrates the feasibility
In addition, because HOPES consists of seven and effectiveness of integrating group-based skills
discrete modules delivered over 1 year followed by training and preventive healthcare targeting older
a second year of monthly booster sessions, our study adults with SMI. An important strength was that
was not designed to assess the comparative or HOPES demonstrated improved independent living
incremental contributions of the individual modules skills and community functioning from multiple
to improved outcomes. A more targeted and indi- perspectives including self-report, case manager
vidually tailored approach may be more effective and observation, and role-play assessments of skills. We
efficient. We are currently engaged in pilot studies also found that integrated preventive healthcare
exploring the feasibility and potential effectiveness of coordination by an embedded nurse can significantly
matching participant need and preference for improve adherence to preventive screening, especially
selected components of HOPES. Finally, although we for procedures such as mammograms and Pap
found statistically significant improvements on smears, in addition to substantially improving
several measures of functioning and symptoms over advance care planning. Finally, HOPES participants
3 years, the clinical significance of these improve- maintained gains in improved functioning and
ments is uncertain. For most of the measures, symptoms at the 3-year follow-up. To our knowledge,
this improvement in functioning provides the longest between science and services provided in the
and largest demonstration of the effectiveness of community. To respond to the rapidly growing
psychosocial skills training for persons with SMI, population of older adults with SMI, a future
regardless of age group. research agenda should include identifying success-
There are several potential implications of these ful strategies for implementing and sustaining effec-
findings. First, as underscored by the 2012 Institute of tive integrated rehabilitation and healthcare services
Medicine Report on the mental health workforce for in the community.
older adults,5 the burgeoning population of older
adults with SMI will require more providers trained The authors thank the following individuals for their
to supply evidence-based practices for this high-risk assistance in conducting this project: Kay Allen, Therese
group.43 HOPES adds to the small number of Andrews, Rachel Berman, Sarah Bishop-Horton, Alice
psychosocial interventions validated for use among Cassidy, Sara Castillo, Martha Curtis, Vanessa D’Anna,
older adults with SMI8,11 and confirms that the Meghan Driscoll, Carol Farmer, Susan Fitzpatrick, Anne
effectiveness of psychosocial rehabilitation is not Fletcher, Carol Furlong, Severina Haddad, Carol Johnson,
limited to younger adults. These interventions may Sarah Kelly, Lisa Kennedy, Meghan Santos, Cynthia
also provide a strategy for responding to the U.S. Meddich, Katie Merrill, Krystal Murray, Brenda Nick-
Supreme Court Olmstead Decision mandating that erson, Thomas Patterson, Reni Poulakos, Christina Riggs,
states provide services supporting the preference of Brenda Wilbert, Joanne Wojcik, and Valerie Zelonis.
adults with disabilities to reside in noninstitutional The study was supported by a grant from the National
settings.2 Finally, there remains a dramatic gap Institute of Mental Health (R01 MH62324).
References
1. Bartels SJ, Miles KM, Dums AR, et al: Factors associated with 10. Patterson TL, McKibbin C, Taylor M, et al: Functional Adaptation
community mental health service use by older adults with severe Skills Training (FAST): a pilot psychosocial intervention study in
mental illness. J Mental Health Aging 2003; 9:123e135 middle-aged and older patients with chronic psychotic disorders.
2. Bartels SJ: Commentary: the forgotten older adult with serious Am J Geriatr Psychiatry 2003; 11:17e23
mental illness: the final challenge in achieving the promise of 11. Patterson TL, Mausbach BT, McKibbin C, et al: Functional
Olmstead? J Aging Soc Policy 2011; 23:244e257 Adaptation Skills Training (FAST): a randomized trial of
3. U.S. Census Bureau: National Population Projections Released a psychosocial intervention for middle-aged and older patients
2008: Table 12: Projections of the Population by Age and Sex for with chronic psychotic disorders. Schizophr Res 2006; 86:
the United States: 2010 to 2050. Washington, DC, U.S. Census 291e299
Bureau, 2008 12. Bartels SJ, Clark RE, Peacock WJ, et al: Medicare and Medicaid
4. Substance Abuse and Mental Health Services Administration: costs for schizophrenia patients by age cohort compared with
MedTEAM: How to Use the Evidence-Based Practices KITs. costs for depression, dementia, and medically ill patients. Am J
Rockville, MD, Center for Mental Health Services, Substance Geriatr Psychiatry 2003; 11:648e657
Abuse and Mental Health Services Administration, U.S. Depart- 13. Bartels SJ, Miles KM, Dums AR, et al: Are nursing homes appro-
ment of Health and Human Services, 2010 priate for older adults with severe mental illness? Conflicting
5. Institute of Medicine: The Mental Health and Substance Use consumer and clinician views and implications for the Olmstead
Workforce for Older Adults: In Whose Hands?. Washington, DC, decision. J Am Geriatr Soc 2003; 51:1571e1579
The National Academies Press, 2012 14. Hendri HC, Lindgren D, Hay DP, et al: Comorbidity profile and
6. Granholm E, Holden J, Link PC, et al: Randomized controlled trial healthcare utilization in elderly patients with serious mental
of cognitive behavioral social skills training for older consumers illnesses. Am J Geriatr Psychiatry 2013; 21:1267e1276
with schizophrenia: defeatist performance attitudes and func- 15. Druss BG, Rosenheck RA, Desai MM, et al: Quality of preventive
tional outcome. Am J Geriatr Psychiatry 2013; 21:251e262 medical care for patients with mental disorders. Med Care 2002;
7. Granholm E, McQuaid JR, McClure FS, et al: Randomized 40:129e136
controlled trial of cognitive behavioral social skills training for 16. Bartels SJ, Forester B, Mueser KT, et al: Enhanced skills training
older people with schizophrenia: 12-month follow-up. J Clin and health care management for older persons with severe
Psychiatry 2007; 68:730e737 mental illness. Commun Mental Health J 2004; 40:75e90
8. Granholm E, McQuaid JR, McClure FS, et al: A randomized, 17. Pratt SI, Bartels SJ, Mueser KT, et al: Helping Older People
controlled trial of cognitive behavioral social skills training for Experience Success: an integrated model of psychosocial
middle-aged and older outpatients with chronic schizophrenia. rehabilitation and health care management for older adults
Am J Psychiatry 2005; 162:520e529 with serious mental illness. Am J Psychiatr Rehabil 2008; 11:
9. Berry K, Purandare N, Drake R, et al: A mixed-methods evaluation 41e60
of a pilot psychosocial intervention group for older people with 18. Mueser KT, Pratt SI, Bartels SJ, et al: Randomized trial of
schizophrenia. Behav Cogn Psychother 2014; 42:199e210 social rehabilitation and integrated health care for older
people with severe mental illness. J Consult Clin Psychol instrument for depression among community-residing older
2010; 78:561e573 adults. Psychol Aging 1997; 12:277e287
19. Pratt SI, Mueser KT, Bartels SJ, et al: The impact of skills training 31. Ware JE Jr, Snow KK, Kosinski M, et al: SF-36 Health Survey
on cognitive functioning in older people with serious mental Manual and Interpretation Guide. Boston, MA, The Health Insti-
illness. Am J Geriatr Psychiatry 2013; 21:242e250 tute, New England Medical Center, 1997
20. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Inter- 32. Charlson M, Pompei P, Ales K, et al: A new method of classifying
view for DMS-IV Axis-I Disorders—Patient Edition (SCID-I/P, prognostic comorbidity in longitudinal studies: development and
Version 2.0). New York, Biometrics Research Department, 1996 validation. J Chronic Dis 1987; 40:373e383
21. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a prac- 33. U.S. Preventive Services Task Force: Recommendations for
tical method for grading the cognitive state of patients for the Adults. Rockville, MD, USPSTF Program Office, 2013
clinician. J Psychiatr Res 1975; 12:189e198 34. Fitzmaurice G, Laird N, Ware J: Applied Longitudinal Analysis.
22. Bellack AS: Skills training for people with severe mental illness. New York, John Wiley & Sons, 2004
Psychiatr Rehabil J 2004; 27:375e391 35. Hedeker D, Gibbons RD: Longitudinal Data Analysis. New York,
23. Wallace CJ, Liberman RP, Tauber R, et al: The Independent Living Wiley, 2006
Skills Survey: a comprehensive measure of the community func- 36. Jennrich R, Schluchter M: Unbalanced repeated-measures models
tioning of severely and persistently mentally ill individuals. with structured covariance matrices. Biometrics 1986; 42:
Schizophr Bull 2000; 26:631e658 805e820
24. Barker S, Barron N, McFarland BH, et al: A community ability 37. Cohen J: Statistical Power Analysis for the Behavioral Sciences,
scale for chronically mentally ill consumers: part I. reliability and 2nd edition. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
validity. Commun Mental Health J 1994; 30:363e379 38. Kazis LE, Anderson JJ, Meenan RF: Effect sizes for interpreting
25. Patterson TL, Goldman S, McKibbin CL, et al: USCD Performance- changes in health status. Med Care 1989; 27:S178eS189
based Skills Assessment: development of a new measure of 39. Laupacis A, Sackett DL, Roberts RS: An assessment of clinically
everyday functioning for severely mentally ill adults. Schizophr useful measures of the consequences of treatment. N Engl J Med
Bull 2001; 27:235e245 1988; 318:1728e1733
26. Wykes T, Sturt E: The measurement of social behaviour in 40. Crowther RE, Marshall M, Bond GR, et al: Helping people with
psychiatric patients: an assessment of the reliability and validity severe mental illness to obtain work: systematic review. BMJ
of the SBS Schedule. Br J Psychiatry 1986; 148:1e11 2001; 322:204e208
27. McDermott BE: Development of an instrument for assessing self- 41. Patterson TL, Bucardo J, McKibbin CL, et al: Development
efficacy in schizophrenic spectrum disorders. J Clin Psychol and pilot testing of a new psychosocial intervention for older
1995; 51:320e331 Latinos with chronic psychosis. Schizophr Bull 2005; 31:
28. Andersen J, Larsen JK, Korner A, et al: The brief psychiatric rating 922e930
scale: schizophrenia, reliability and validity studies. Nord J 42. Mausbach BT, Bowie CR, Harvey PD, et al: Usefulness of the
Psychiatry 1986; 40:135e138 UCSD Performance-Based Skills Assessment (UPSA) for predicting
29. Andreasen NC: Modified Scale for the Assessment of Negative residential independence in patients with chronic schizophrenia.
Symptoms. Bethesda, MD, U.S. Department of Health and Human J Psychiatr Res 2008; 42:320e327
Services, 1984 43. Bartels SJ, Naslund JA: The underside of the silver tsunami—
30. Lewinsohn PM, Seeley JR, Roberts RE, et al: Center for Epidemi- older adults and mental health care. N Engl J Med 2013; 368:
ologic Studies Depression Scale (CES-D) as a screening 493e496